Pembrolizumab in Small Cell Carcinoma of Ovary - Hypercalcemic Type Patient
Clinical trial NCT05368207 · COMPLETED
Trial details
- NCT number
- NCT05368207
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-06
- Primary completion
- 2025-10-16
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.